Meet Ex-CDEX engineer in charge of products and design, Jim M Ryles.


http://investorshub.advfn.com/boards/read_msg.aspx?message_id=84714375


http://profileengine.com/people/214086916/jim.m.ryles#/people/214086916/jim.m.ryles

Jim M. Ryles?Pima County Master Gardeners
What is this plant? Seeds look like a chuparosa. — in Tucson, Arizona.

A VERY HAPPY NEW YEAR TO CDEX SHAREHOLDERS.

CDEX's director, Dr. Jason Terrell, is the Head Of US Operations at VolitionRx. Dr. Terrell's cancer diagnostics company VolitionRx Ltd. filed for an IPO (initial public offering) on the NYSE MKT Dec 12, 2014

The New York Stock Exchange (NYSE) is considered the largest equities-based exchange in the world based on total market capitalization of its listed securities. Also known as the "Big Board."

http://www.bioportfolio.com/news/article/2168433/VolitionRx-files-for-IPO-on-NYSE.html

December 12, 2014

VolitionRx files for IPO on NYSE

http://www.prnewswire.com/news-releases/volitionrx-hires-head-of-us-operations-jason-terrell-md-200008891.html

March 26, 2013

VolitionRx Hires Head of US Operations, Jason Terrell MD

http://finance.yahoo.com/news/CDEX-Appoints-Dr-Jason-B-iw-3830890938.html

January 26, 2012

CDEX Appoints Dr. Jason B. Terrell as Medical Director

Dr. Terrell is currently a corporate medical director for Any Lab Test Now©, the largest direct access medical testing franchise in the United States. Dr. Terrell currently owns and operates multiple medical laboratory testing facilities in the Southwest United States. He earned his Bachelor of Science in Biochemistry from Hardin-Simmons University, graduating Summa Cum Laude and recipient of the Holland Medal of Honor. He earned his MD from the University of Texas at Houston School of Medicine.

"I am excited to join the outstanding team at CDEX. The technology promises to have a global impact in multiple industries. I believe the Valimed G4 will revolutionize parenteral medication safety practices and narcotic diversion control in both healthcare and closely related industries," stated Jason B. Terrell, M.D., medical director of CDEX. "What's really exciting is that CDEX's patented technology can be applied to the analysis of blood, urine, saliva, and other bodily fluids. Preliminary data suggests that the technology provides many advantages over current diagnostics techniques, including the ability to detect lower molecular concentrations, increased sensitivity and specificity with real-time analysis. One of my goals as medical director is to facilitate additional research studies and trials in these areas to expand future product use."

A very Merry Christmas to CDEX shareholders!

CDEX's Dr John P Coates co-authored this hardback avail on Amazon

Seems he has been a widely acknowledged expert in Characterization by Infrared Spectra for some time




http://www.amazon.com/Oils-Lubricants-Petroleum-Products-Characterization/dp/0824774124

CDEX's Dr John Coates - coming in January 2015 - Process Spectroscopy Chairs: John Coates, Coates Consulting and Bob Bear, Ametek




http://www.ifpac.com/IFPAC15/IFPAC2015ShowPreviewAllSessions20141111.pdf




A bit more from Dr. Coates co-presenter. Robert Bear, Ametek




http://www.scribd.com/doc/207684406/Reducing-the-Detection-Limits-for-a-Process-Moisture-Analyzer

CDEX WEBSITE: http://cdex-inc.com/

CDEX's Dr John Coates - IFPAC 2014 (just look at the IFPAC folks!)

http://www.ifpac.com/cgi-bin/OnSiteProgram2014.pl

http://www.infoscience.com/JPAC/ManScDB/JPACDBEntries/1394038429.pdf

New Small Spectrometer Concepts
Covering the Ultraviolet to the
Mid-Infrared
John Coates
Coates Consulting
Process Spectroscopy
IFPAC-2014
Thursday PM VIII

CDEX is gaining followers on Twitter

https://twitter.com/cdex_inc

CDEX's Dr John Coates - IFPAC 2014 (just look at the IFPAC folks!)

http://www.ifpac.com/cgi-bin/OnSiteProgram2014.pl

A Review of New Small-Scale Technologies for Near Infrared Measurements

John Coates, Coates Consulting LLC, Newtown, CT

http://www.ifpac.com/HomePage.html

IFPAC SCIENTIFIC BOARD

Co-Chairs
Scott Armstrong, ExxonMobil, Baton Rouge, LA
John Kauffman, FDA, CDER, OPS, OTR, DPA, St. Louis, MO
G.K. Raju, Light Pharma, Cambridge, MA
Martin Warman, Vertex Pharmaceuticals, Boston, MA

Members
Lucinda Buhse, FDA, CDER, OPS, OTR, DPA, St. Louis, MO
Sharmista Chatterjee FDA, CDER, OPS, ONDQA, Silver Spring, MD
James Cheney,Celgene, Summit, NJ
John Crandall,Falcon Analytical, Ronceverte, WV
Troy Francisco, DuPont Company, Wilmington DE
Rick Friedman, FDA, CDER, OMPQ, OC, OMPT, Silver Spring, MD
Steve Hammond Pfizer, Inc., Morris Plains, NJ
Walter Henslee JPAC, McDade, TX
Mel Koch APL, Univ. of Washington, Seattle, WA
Evdokia Korakianiti EMA
Theodora Kourti GlaxoSmithKline
Steve Kozlowski FDA, CDER, OPS, OBP, Silver Spring, MD
Mark A. LaPack Eli Lilly & Company, Indianapolis, IN
Lorenz Liesum, Novartis Pharma, Basel, Switzerland
Gawayne Maboubian-Jones Philip Morris International, Neuchatel, Switzerland
Matthew H. MacConnell, Air Products and Chemicals, Allentown, PA
Christine M. Moore FDA, CDER, ONDQA, OPS, Silver Spring, MD
Fernando Muzzio Rutgers University, New Brunswick, NJ
Moheb M. Nasr GSK
Manoharan Ramasamy, Merck & Co., Inc, West Point, PA
Brian Rohrback Infometrix, Inc., Bothell, WA
Tim Stevens, Bristol-Myers Squibb, New Brunswick, NJ
J.D. Tate Dow Chemical, Freeport, TX
Gert Thurau Hoffman-La Roche, Basil, Switzerland
Cenk Undey Amgen, Thousand Oaks, CA
Paul Vahey The Boeing Company, Boeing Research and Technology, Seattle, WA
Jeffrey W. Weber, Pfizer, Kalamazoo, MI

Representatives
Stephen Byrn CPPR/PTCC/CAMP, Purdue University, West Lafayette, IN
James Drennen III and Carl Anderson DCPT, Duquesne University, Pittsburgh, PA
Brian Marquardt Director, CPAC, APL, Univ. of Washington, Seattle, WA
Jose Cardoso de Menezes IST, UTL, Portugal
Fernando Muzzio Rutgers University, New Brunswick, NJ
Michael J. Tarlov NIST, Gaithersburg, MD

IFPAC Director
Robert S. Zutkis, IFPAC, Grayslake

CDEX questions: Pennstreet, under what circumstances was Ryles dismissed? Did Mr. Brumfield have anything to do with him being kicked out? Do you think Ryles has a vendetta against Cdex?

CDEX: Anybody else find it interesting that CDEX's Dr John Coates work is on the SAE International website?

http://profiles.sae.org/john_p._coates/

CDEX's Dr John Coates - his profile is on LaserFocusWorld

http://www.laserfocusworld.com/speakers/dr.-john-coates.html

Dr. John Coates

President

Coates Consulting


John P. Coates is the founder and principal of Coates Consulting (Newtown, CT). He obtained his PhD in analytical chemistry from Brunel University, West London, England on the chemistry of synthetic gas-turbine engine oils. He has extensive experience in industry, including at Burmah-Castrol (Glasgow, Scotland) and Nicolet Instrument Corporation (Madison, WI). He is currently a consultant in the area of scientific and industrial instrumentation

CDEX PARTNERS - SEC 10K Report:

http://www.sec.gov/Archives/edgar/data/1173738/000121465914001096/s21114010k.htm

Our partners continue to be invaluable in the development of the final form and function of our ValiMed G4 technology. On numerous occasions throughout 2013, our personnel have traveled to each site working with our partners in determining the “real world” needs, applications, and challenges of fully implementing VG4 technology. This effort should prove out to be a most crucial step in the process to insure a successful launch into the mainstream marketplace of the hospital pharmacy environment

Demand and interest in our VG4 technology is very high, and continues to grow. Through current relationships, attendance at numerous trade shows, our web site, and word of mouth throughout the industry, we are in negotiation for multiple placements which include; a university hospital, teaching hospitals, general hospitals, clinics, and children’s hospitals all around the country, and internationally. This new approach for CDEX, of having a few select hospitals as beta site partners, has proven to be a critical step which has provided the necessary data, and details for the development of the final product. Although this step has delayed the launch of VG4 platform, it has proven to be a vital tool for an anticipated successful future launch for the VG4.

Research and Development (“R&D”)

In 2014, we expect to continue the exploration and development of new capabilities for our VG4 technology, such as expanding the signature libraries of detectable drugs and improving multi-component capabilities. Additionally, we anticipate to partner with a major Midwestern university hospital to develop an oncology formulary, and possibly the detection of drugs in blood and/or urine, such as banned performance enhancing drugs, HGH, and HCG. If demand and budget allows we also expect to begin development research in creating a portable VG4 unit, which could be utilized to service the smaller hospitals, pain centers, and convalescent hospitals, in their fight against narcotics diversion.

US Patent Office Granted CDEX Patent #8,848,173 in September, 2014 Inventors Poteet; Wade M. (Vail, AZ), Starzinger; Carey W. (Benson, AZ), Brumfield; Jeffery K. (Romona, CA) HERE IS WHAT IT SAYS:

A method to identify or quantify a substance using enhanced photoemission spectroscopy (EPS), the method comprising: performing at least three light or photoelectric processes simultaneously to generate reflected energy from the target substance within a container, wherein the processes include Raman scattering detection, fluorescence detection and spectral surface reflectance detection; processing the reflected energy from the at least three processes to generate spectral data for the target substance; comparing at least one peak value associated with the Raman scattering detection with at least one value for the container; adjusting the spectral data for the target substance based on the comparison by removing the at least one value for the container; and comparing target signatures derived from the adjusted spectral data to stored signature data to produce identification and concentration of an unknown substance or verification of a known substance. The method of claim 13, wherein the processing step includes adjusting the spectrum data in accordance with a container enclosing the target. The disclosed embodiments measures these properties directly and also indirectly, such as through containers that are transparent or semi-transparent. he containers discussed below may be transparent or semi-transparent. For example, the preferred container may pass wavelengths of about 430 nm to 929 nm of light up to an attenuation factor between 75% to 95%. Examples includes, but are not limited to, clear glass vials, brown glass vials, syringes of any FDA-approved plastic material, IV bags of any manufacture, glass jugs, plastic jugs, drinking water containers, perfume bottles, liquor/beer bottles, soda/energy drink/sports drink containers, explosive wrapping materials, and the like. A correction for sample container effects, therefore, is realized in the disclosed embodiments. No attempt to suppress fluorescent energy from sample 110 is made. Data modules 124-28 also may access signature information for known containers so that they may subtract this information from the returned energy information processed by AWC spectrometer 112. Thus, containers may be accounted for and removed from the overall data so that sample 110 is properly identified. Preferably, data modules 124-28 include algorithms, as disclosed below, to give a high degree of certainty for matching the spectral information from all three processes to stored signature data.

The disclosed embodiments implement EPS processing to utilize the data fusion of all three processes disclosed above to determine factors about the target substance, shown as sample 110. The disclosed processes may determine the specific molecule, the concentration of that molecule in a target or mixture, and the separation of constituents in a multi-molecular mixture. Additionally, the data produced in this method allow the effects of a transparent intermediate material, such as a container or wrapper, to be accounted for and, thus, eliminated as a source of extraneous return information from the identification/concentration determining process.

ENGINEER "JIM RYLES"--WHO LIKENS IT TO ANOTHER POPULAR LAW ENFORCEMENT DEVICE.

"A breathalyzer takes some consent--this may not take some consent ifyou just do the door handles of the car or whatever," Jim Ryles says from CDEX's eastside facility. "The officer scans quickly and then looks at the machine and realizes perhaps he has cause to search further."

Who said what about the Meth Gun?

http://www.kold.com/Global/story.asp?S=5148339&nav=14RTKgB1Tucson
Company Touting "Meth Gun"

Tucson Company Touting "Meth Gun"!

By Som Lisaius, KOLD News 13

WHILE IT LOOKS LIKE A BLOWDRYER, THIS HANDHELD DEVICE MAY BE THE FUTURE OF DETECTING ILLEGAL DRUGS--ESPECIALLY METHAMPHETAMINE.

"The meth gun uses spectroscopy to identify the chemical signatures of drugs."

IN LAY TERMS...THAT'S ULTRA-VIOLET LIGHT THAT ILLUMINATES EVEN THE
SMALLEST AMOUNTS OF METHAMPHETAMINE.

"You would aim, point, shoot--and it would say meth for truly invisible quantities on the contaminated surface."

DR. LARRY MARSTELLER IS CO-INVENTOR OF THE CDEX METH GUN. AS IS
ENGINEER "JIM RYLES"--WHO LIKENS IT TO ANOTHER POPULAR LAW ENFORCEMENT
DEVICE.

"A breathalyzer takes some consent--this may not take some consent ifyou just do the door handles of the car or whatever," Jim Ryles says from CDEX's eastside facility. "The officer scans quickly and then looks at the machine and realizes perhaps he has cause to search further."

Right now the CDEX meth gun is only a prototype. But the Tucson-based
company expects its first meth gun to hit law enforcement agencies
around the country by the end of this year.

TO DATE, NO LOCAL AGENCIES HAVE BOUGHT INTO THE DEVICE WHICH IS
EXPECTED TO SELL FOR SLIGHTLY UNDER 10-THOUSAND DOLLARS. BUT THE
INNOVATIVE PRODUCT IS DRAWING INTEREST ELSEWHERE.

THIS WEEK, THE PROTOTYPE WAS PRESENTED TO LAW ENFORCEMENT OFFICIALS AND
HAZMAT TEAMS ON THE EAST COAST. WHILE THEY'RE ADMITTEDLY OPTIMISITIC,
C-DEX HOPES TO SEE A METH GUN IN EVERY POLICE CRUISER NATIONWIDE WITHIN
THE NEXT THREE YEARS.

CDEX tech director runs with the big dogs because John Coates, PhD, documented as a 4-year voting board member, of the Coblentz Society, and just look at the people this org links to, particularly in the world of needed spectroscopy applications like MIT, DOW Chemical, Perkin Elmer, Battelle, Beckman Instruments, National Institutes of Health, Naval Research Laboratory,National Science Foundation, Lawrence Livermore National Lab, Los Alamos National Laboratory, Philip Morris Research & Development, Sandia National Laboratories, IBM, University of Michigan, 3M, SmithKline Beecham, Procter & Gamble Company,Merck, the FDA Food and Drug Administration, and many more, so with Doctor Coates working in this current beta partnering phase, CDEX will fly when it goes from beta partner site numbers to numbers that fulfill the orders CDEX has described to us all through the SEC, like Once the beta testing is completed, we expect to launch our system soon thereafter. The next phase of development will be to begin building the oncology formulary. There are over seven hundred institutions in the United States that administer oncology drugs, and due to the toxic nature and expense of these drugs, we expect to partner with a large teaching hospital in the Midwest to help us build the oncology library. We anticipate this endeavor will start in the fourth quarter of 2014. Our partners continue to be invaluable in the development of the final form and function of our ValiMed G4 technology. On numerous occasions throughout 2013, our personnel have traveled to each site working with our partners in determining the “real world” needs, applications, and challenges of fully implementing VG4 technology. This effort should prove out to be a most crucial step in the process to insure a successful launch into the mainstream marketplace of the hospital pharmacy environment Demand and interest in our VG4 technology is very high, and continues to grow. Through current relationships, attendance at numerous trade shows, our web site, and word of mouth throughout the industry, we are in negotiation for multiple placements which include; a university hospital, teaching hospitals, general hospitals, clinics, and children’s hospitals all around the country, and internationally. This new approach for CDEX, of having a few select hospitals as beta site partners, has proven to be a critical step which has provided the necessary data, and details for the development of the final product. Although this step has delayed the launch of VG4 platform, it has proven to be a vital tool for an anticipated successful future launch for the VG4.

http://www.coblentz.org/home/past-officers

By John Coates, now with CDEX, INC in 2014

Today's Raman systems feature low-power near infrared (NIR) lasers, operating with a few hundred mW of power. The NIR wavelength of incident light reduces the occurrence of flu orescence and the lower power aids laser safety. The key to improved performance of modern instruments is, in part, due to improved photon management. The handheld analyzer covered in this article(Ahura Corp., Wilmington, MA) is an example of optimized light management, by providing a simple-to-use sample interface, with minimal issues relative to laser safety.




http://www.spectroscopyonline.com/spectroscopy/Molecular+Spectroscopy+Workbench+Column/New-Technologies-for-Process-Analytical-and-Qualit/ArticleStandard/Article/detail/309543?contextCategoryId=36822

Check out these links with CDEX's J Coates, PhD

Perkin Elmer, Ocean Optics, Smiths Detection, Ahura ...how many know Coates? How many worked with him directly?.

http://www.lens.org/lens/patent/US_6707043_B2/fulltext

http://patft.uspto.gov/netacgi/nph-Parser?Sect1=PTO2&Sect2=HITOFF&p=1&u=%2Fnetahtml%2FPTO%2Fsearch-bool.html&r=1&f=G&l=50&co1=AND&d=PTXT&s1=10%2F201,184&OS=10/201,184&RS=10/201,184

https://www.google.com/url?sa=t&rct=j&q=&esrc=s&source=web&cd=3&cad=rja&uact=8&ved=0CCkQFjAC&url=http%3A%2F%2Fwww.researchgate.net%2Fprofile%2FLinda_Kidder%2Fpublication%2F227990894_NearInfrared_Chemical_Imaging_as_a_Process_Analytical_Tool%2Flinks%2F09e4151069a96765ce000000&ei=zyRRVJLLN8mnNv7UgcAL&usg=AFQjCNHPHYzb4eHGOjsQPBCrLfn8c8U2gA&bvm=bv.78597519,d.eXY

CDEX's Dr. Coates: New Microspectrometers - Building on the principle that simple is beautiful.

Another great thing about this is it is on the University of Texas website.

http://www.uta.edu/rfmems/Teralum_old/6594611.pdf

CDEX's Dr. Coates: New Microspectrometers - Building on the principle that simple is beautiful.

http://www.uta.edu/rfmems/Teralum_old/6594611.pdf

CDEX's Dr. James Stevenson....check this out!

http://visanteinc.com/consultants/james-stevenson-president-hospital-health-systems-services-visante-inc-and-visante-ltd/

CDEX's James Stevenson. Facility Instructor leading for technology advancement.

http://www.ashpfoundation.org/2014module6syllabus

2013 Course Syllabus Module 6

MODULE TITLE
Leading for Technology Advancement
INSTRUCTOR QUALIFICATIONS

Faculty:
James G. Stevenson, PharmD, FASHP
Jim received his undergraduate degree in Pharmacy and Doctor of Pharmacy
degrees from Wayne State University. He served on the faculty of the West
Virginia University School of Pharmacy and as Director of Pharmaceutical Services
at West Virginia University Hospitals. In 1991 he was named Director of Pharmacy
Services at Detroit Receiving Hospital and University Health Service and Director of
the Graduate Program in Health-System Pharmacy Management in the Wayne State
University College of Pharmacy. In 1997 he was named Executive Director of
Pharmacy Services for the 8-hospital Detroit Medical Center. In 1999 Jim assumed
the position of Director of Pharmacy Services for the University of Michigan
Hospitals and Health Centers and Professor and Associate Dean for Clinical Sciences
in the University of Michigan College of Pharmacy. He was promoted to Chief
Pharmacy Officer and also assumed the responsibilities of Chair of the Department
of Clinical, Social, and Administrative Sciences in 2011. He is a Fellow of the
American Society of Health-System Pharmacists and has been recognized as
Pharmacist of the Year by both the Michigan Society of Health-System Pharmacists
and the Michigan Pharmacists Association. He has been honored with the
Distinguished Alumnus Award by the Wayne State University College of Pharmacy
and the Joe Oddis Leadership Award by the Michigan Society of Health-System Pharmacists.

He completed a term of service on the Board of Directors of ASHP
and received the 2010 John W. Webb Lecture Award for extraordinary dedication to
fostering excellence in pharmacy management. He was appointed in 2012 to the
Michigan Board of Pharmacy and is the recipient of the 2013 ASHP Award for
Distinguished Leadership in Health-System Pharmacy Practice. His research
interests are in pharmacy practice management, pharmacoeconomics, pharmacy
informatics, and medication safety.

CDEX's Dr. John Coates, June 2014 - A Review of New Small-Scale Technologies for Near Infrared Measurements


http://www.americanpharmaceuticalreview.com/Featured-Articles/163573-A-Review-of-New-Small-Scale-Technologies-for-Near-Infrared-Measurements/

CDEX's Dr. Coates: SHEDDING NEW LIGHT ON MATERIALS ANALYSIS: TUNABLE MID-IR LASER SPECTROMETRY




http://www.spectroscopyonline.com/spectroscopy/author/authorInfo.jsp?id=19232

CDEX's John Coates, PhD: Ahura Corporation (homeland defense) – handheld Raman – applications GOSH!


CDEX's John Coates, PhD: SensIR Technologies/Smiths Detection - FTIR accessories including FTIR/ATR – applications and product development GEE!

And of course, we ALL know where the FBI might have interests in advanced detection technology.....

CDEX's John Coates, PhD: FBI (Infrared Technology and Data Interpretation) – forensic training

http://www.coates-consulting.com/services.html

Did you see the CDEX announcement made it to Bloomberg ???

CDEX Expands Technical Development Team With Appointment of John Coates, Ph.D. as Technical Director for Spectroscopy Products

http://www.bloomberg.com/article/2014-08-18/aVyS7P56bs_c.html

CDEX's John Coates work is referenced by many..... here are some examples

U.C. Davis

ChemWiki: The Dynamic Chemistry E-textbook > Physical Chemistry > Spectroscopy > Vibrational Spectroscopy > Infrared Spectroscopy > Infrared: Interpretation

http://chemwiki.ucdavis.edu/Physical_Chemistry/Spectroscopy/Vibrational_Spectroscopy/Infrared_Spectroscopy/Infrared%3A_Interpretation
Berkeley Lab ALS Infrared Beamlines

http://infrared.als.lbl.gov/BLManual/IR_Interpretation.pdf

Written and published by CDEX's Dr. John Coates in Encyclopedia of Analytical Chemistry

Interpretation of Infrared Spectra, A Practical Approach

With liquids, it is always beneficial to examine the
sample as it is received. Liquid transmission cells have
been used successfully in the past, but care and attention
must be paid to the nature of the window material and
to the cell pathlength. Low-molecular-weight materials
usually require very short pathlengths in order to obtain a
good-quality spectrum with most of the absorption bands
on-scale. If too many bands bottom out, it is difficult to
ascertain the relative intensity of certain key functional
groups, and sometimes key factors, such as band splitting,
may be missed. Also, if the sample is of low molecular
weight, and volatile, it is important to ensure that the cell
seals adequately.

In recent years, focus has been placed on reflectance
methods of measurement, primarily from the surface
of a sample. The most common methods are diffuse
reflectance, specular reflectance and/or transflectance,

and ATR. Generally, these are non-destructive methods.......




http://www.spectroscopynow.com/userfiles/sepspec/file/specNOW/eac10815.pdf

Sure seems Perkin Elmer likes CDEX's John Coates. Now CDEX will advance even more with his guidance. He was Chief Chemist, IR and NMR Specialist, AND A DIRECTOR at Perkin-Elmer, which is impressive because today Perkin Elmer boasts an outstanding team of 7,600 employees and located in over 150 countries across the world

http://www.coates-consulting.com/aboutus.html

Where CDEX's John Coates, PhD comes from (among other leading technology companies as well !)

http://www.perkinelmer.com/OurCompany/AboutUs/default.xhtml

Dr. Coates is especially interesting for us in CDEX in my opinion, because our new tech director has significant experience with instrumentation - laboratory, process, sensors and specialist applications, major focus on optical spectroscopy, as well as experience with medical and clinical diagnostics


August 2014 CDEX appoints John Coates, Ph.D. as Technical Director for Spectroscopy Products


http://cdex-inc.com/cdex-expands-technical-development-team-with-appointment-of-john-coates-ph-d-as-technical-director-for-spectroscopy-products/

CDEX Granted Notice of Allowance for U.S. Patent Application Covering Identification and Determination of Chemical Substances Using Enhanced Photoemission Spectroscopy

TUCSON, AZ--(Marketwired - Jul 31, 2014) - CDEX Inc. (CDEX) (OTCQB: CDEX), a pioneering developer, manufacturer and distributor of patented, real-time chemical detection and validation technologies for the healthcare and security markets, today announced that the U.S. Patent and Trademark Office has granted a Notice of Allowance for U.S. Patent Application No. 13/673,270 with claims that cover methods for identifying and determining unknown substances using enhanced photoemission spectroscopy ("EPS").

Jeffrey Brumfield, CDEX Chairman and CEO, stated, "Issuance of this patent will further strengthen and extend what we believe is CDEX's leading position as a true innovator in our industry. Moreover, these claims provide significant protection for our proprietary EPS technology, constitute yet another stamp of approval for the validity and innovative aspects of our proprietary products currently being commercialized, and empower us with crucial competitive distinction in the global marketplace."

This new patent joins previously issued U.S. patents, which comprise a platform portfolio of technologies, systems and methodologies underlying CDEX's first commercial innovations: TheValiMed™ System, which provides real-time validation of drugs or the detection of foreign materials; the ID2™ Meth Scanner, a hand-held, battery-operated scanner for detecting all forms of methamphetamines; and the Pocket ID2™, which provides a more portable and easily concealed device for convenience and security purposes use in law enforcement, prisons, homeland security, border patrol, port authorities and other applicable environments.

Check out this link to John Coates on Infrared Spectroscopy!

http://www.spectroscopynow.com/userfiles/sepspec/file/specNOW/eac10815.pdf

CDEX Inc. to Present at the National Investment Banking Association's 132nd Investment Conference
Marketwire - Mon Aug 25, 7:31AM CDT
CDEX Inc. (OTCQB: CDEX), a pioneering developer, manufacturer and distributor of patented, real-time chemical detection and validation technologies for the healthcare and security markets, today announced that the Company has been invited to present at the National Investment Banking Association's ("NIBA" 132nd Investment Conference to be held in New York on September 15-17, 2014.

CDEX Expands Technical Development Team With Appointment of John Coates, Ph.D. as Technical Director for Spectroscopy Products
Marketwire - Mon Aug 18, 7:30AM CDT
CDEX Inc. (OTCQB: CDEX), a pioneering developer, manufacturer and distributor of patented, real-time chemical detection and validation technologies for the healthcare and security markets, today announced the expansion of its technical development team with the appointment of John Coates, Ph.D. as Technical Director for Spectroscopy Products.

CDEX Granted Notice of Allowance for U.S. Patent Application Covering Identification and Determination of Chemical Substances Using Enhanced Photoemission Spectroscopy
Marketwire - Thu Jul 31, 7:30AM CDT
CDEX Inc. (OTCBB: CDEX) (OTCQB: CDEX), a pioneering developer, manufacturer and distributor of patented, real-time chemical detection and validation technologies for the healthcare and security markets, today announced that the U.S. Patent and Trademark Office has granted a Notice of Allowance for U.S. Patent Application No. 13/673,270 with claims that cover methods for identifying and determining unknown substances using enhanced photoemission spectroscopy ("EPS" .

CDEX Completes Shipment of 10 ValiMed CCT Systems Ahead of Schedule
Marketwire - Mon Mar 25, 8:30AM CDT
CDEX Inc. (OTCQB: CDEX), a leading developer of chemical detection products using patented technologies for use in healthcare, safety and security markets, today announced the company completed and shipped the 10 unit order of its ValiMed(TM) CCT drug validation system to Al-Essa Medical & Scientific Equipment Company in Safat, Kuwait ahead of schedule. The shipment completes the sale secured in December of 2012. The units will be placed in service at medical facilities throughout the region along with testing supplies for initial operation. Each unit placed requires additional service for installation and ongoing product support by CDEX for two years from the date of delivery.

CDEX: The VG4 system uses a patented detection process providing a real time (within seconds) and quantitative (strength/concentration), as well as qualitative (identification of an unknown) analysis of high-risk single component compounded medications and treatment solutions. The Valimed CCT system that is operating in various hospital settings around the country, provides the healthcare industry with verification of a known substance, primarily a known drug with a known strength/concentration, in a known diluent. This system also utilizes its proprietary cuvettes in the process. Both devices help healthcare facilities comply with Joint Commission on Accreditation of Healthcare Organizations compliance requirements and United States Pharmacopeia's General Chapter 797 Pharmaceutical Compounding—Sterile Preparations guidelines for compounding sterile preparations.



http://investing.businessweek.com/research/stocks/snapshot/snapshot_article.asp?ticker=CDEX

CDEX on FaceBook, and CDEX DIRECTOR Dr. Jason Terrell - MD Anderson Collaborates with VolitionRx to Evaluate Prostate Cancer Diagnostic Tool

http://bionews-tx.com/news/2014/10/08/md-anderson-collaborates-with-volitionrx-to-evaluate-prostate-cancer-diagnostic-tool/

About MD Anderson

We shall be the premier cancer center in the world, based on the excellence of our people, our research-driven patient care and our science.

We are Making Cancer History.

http://www.mdanderson.org/about-us/index.html

About Jason Terrel, M.D.

http://finance.yahoo.com/news/CDEX-Appoints-Dr-Jason-B-iw-3830890938.html

CDEX shared a link via their FaceBook page.....


In 2011, ISMP gave the results of a five-hospital observational study on small and large volume injectables, chemotherapy solutions, and parenteral nutrition. The study found a "mean error rate of 9%, meaning almost 1 in 10 products was prepared incorrectly and then dispensed." And the study found "Error rates for complex solutions such as parenteral nutrition were especially high."



https://www.facebook.com/CdexInc

CDEX has pioneered proprietary, patented technology applied to create and bring to market two in-demand, proprietary product lines. CDEX has created an extensive and very valuable library of reference signatures (200+ for current CCT Model) and an ever expanding signature library for the ValiMed G4 Our research and development efforts have centered on, but are not limited to, the use of excitation energy sources and patented/patents pending processing technology for substance verification, authentication and identification.Our ValiMed Medication Validation System (“MVS”) product line – consists of two products: our third generation ValiMed system, marketed as ValiMed CCT (“CCT”)and the ValiMed G4 (“VG4”). Both ValiMed systems help healthcare providers ensure patient safety and control costs by reducing medication errors and mitigating drug diversion, utilizing our patented and patent pending process known as Enhanced Photoemission Spectroscopy.The VG4 system uses a patented detection process providing a real time (within seconds), quantitative (strength/concentration) and qualitative (identification of known) analysis of high-risk single component compounded medications and treatment solutions. The CCT system, which is operating in numerous hospital settings around the country, provides the healthcare industry with the ability to verify a known substance, specifically a known drug with a known strength/concentration, in a known diluent. The CCT system also utilizes our proprietary cuvettes in the process. Both devices help healthcare facilities comply with Joint Commission on Accreditation of Healthcare Organizations compliance requirements and United States Pharmacopeia's General Chapter 797 Pharmaceutical Compounding—Sterile Preparations (“USP 797”) guidelines for compounding sterile preparations. Both systems also provide a recurring revenue stream and address three problem areas in the healthcare market: (i) human error in the compounding of medications, with an emphasis on, but not limited to high risk medications; (ii) harmful counterfeit medications and (iii) diversion of hospital narcotics.In the near future, we expect the VG4 product line to address multi component compounded admixtures, such as total parenteral nutrition. We expect to add oncology drugs to our formulary in 2016 as well. One of the most significant improvements with the VG4 is the capability to analyze through most containers that are currently being used in pharmaceutical settings. This provides our end users with a more streamlined application, with less labor and without compromising the sterility of the compounded admixtures.Our ID2 product line – provides solutions for real time (within seconds) detection of specified illegal drugs. This product line currently comprises two devices, both which are hand-held models that detect methamphetamine. The ID2 Meth Scanner is a device that is used for the detection of methamphetamine in the home inspection industries, by housing authorities, the hotel industry and in our nation’s prisons and correctional facilities. The Pocket ID2 is a pocket-sized hand-held device that currently detects visible and prosecutable quantities of methamphetamine. We expect to expand our detection capabilities to include other drugs such as cocaine, heroin, OxyContin and Ecstasy in the near future.We continue to explore opportunities to apply the ID2 technology to a table top device that will be portable and able to detect trace amounts of specified illegal drugs and explosives in real-time. Our ID2 products have applications in all areas of law enforcement, including local police and sheriff departments, U.S. border patrol, port authorities, TSA, FBI, U.S. Military, and other agencies engaged in counternarcotics.

http://www.sec.gov/Archives/edgar/data/1173738/000121465914006429/n9914010q.htm

CDEX TECH DIR JOHN COATES PHD =

Visualization of Micro-ATR Infrared Spectroscopy
John P. Coates and John Reffner
The authors present an explanation of the principles along with a historical perspective of ATR and point out the areas in which it is most valuable.


A Review of Current and New Technologies Used in Instrumentation for Industrial Vibrational Spectroscopy
John Coates
The author reviews the history of infrared, near-infrared, and Raman spectroscopy for use as industrial QC or process control instruments, including the benefits and disadvantages of spectroscopy in these settings

http://www.techexpo.com/toc/spctrs99.html

CDEX's Dr. Coates has to his credit multiple cited publications, issued patents, and he serves as a reviewer of technical publications.

He will certainly be a strong technical representative along side Dr. Terrell and Mr. Brumfield at this weeks event.

John P. Coates, PhD is an acknowledged reviewer of:
CRC Handbook of Fundamental Spectroscopic Correlation Charts

CDEX's Dr. Coates also has to his credit:

.1. Coates, J.P., “Thin Layer Chromatography of Lubricating Oils”, J.Inst.Pet., 57, (197l), pp. 209-218.

1.2. Coates, J.P., “The Role of TLC in the Analysis of Lubricants and Allied Materials”, “Quantitative Thin Layer Chromatography”, Fisons Scientific Apparatus, January, 1971, pp. 99 -131 -- book chapter.

1.3. Coates, J.P., “Laser Raman Spectroscopy in the Oil Industry” “Recent Analytical Developments in the Petroleum Industry”, Ed. D.R. Hodges, Applied Science Publishers, Essex, England, (1974), pp. 13-44 -- book chapter.

1. 4. Coates, J.P., “An Approach to Microsampling by Infrared Spectroscopy”, Int. Lab., ?, (l), pp. (1977).

1.5. George, W.O. and Coates, J.P., “Trace Analysis by Infrared Spectroscopy”, “Vibrational Spectroscopy -- Modern Trends”, Ed. A.J.Barnes and W.J.Orville Thomas, Elsevier, (1977), pp. 103-120 -- book chapter.

1.6. Coates, J.P., “Infrared Analysis of Toxic Dusts: Part 1, Analysis of Collected Samples of Quartz and Asbestos”, Am. Lab., 9, (11), pp. 105-111, (1977).

1.7. Coates, J.P., “IR Analysis of Toxic Dusts: Part 2, Analysis of Collected Samples of Asbestos”, Am. Lab., 9, (12), pp. 57-65, (1977).

1.8. Coates, J.P., “The Analysis of Aqueous Solutions by Infrared Spectroscopy", European Spectroscopy News”, 16, (1978), pp. 25-30.

1.9. Coates, J.P. and Geary, S., “Low Cost Infrared Data Systems -- Design and Application”, Anal. Chim. Acta, Computer Techniques and Optimization, 103, (1978), pp. 303-311.

1.10. Coates J.P., “Industrial Applications of Computerized Dispersive Infrared Spectroscopy for Analysis in Solution”, Anal. Chim. Acta, Computer Techniques and Optimization, 103, (1978), pp. 323-338.

1.11. Hannah, R.W. and Coates, J.P., “Microprocessors for Infrared Spectroscopy”, European Spectroscopy News, 32, (1980), pp. 30-35.

1.12. Hannah, R.W., Coates, J.P., Savitzky, A., Ford, M.A. and Carter, H.V., “A Method and Apparatus for Determining the Nature of an Unknown Substance”, U.S. Patent No. 4,365,303, December 1982.

1.13. Coates, J.P. and Setti, L.C., “Performance and Applications of the Perkin- Elmer 1500 Series Fourier Transform Spectrometers”, Perkin-Elmer Publication L -784, 1983 -- monograph.

1.14. Coates, J.P. and Setti, L.C., “Condition Monitoring of Crankcase Oils Using Computer Aided Infrared Spectroscopy”, “Lubricant and Additive Effects on Engine Wear”, SAE Paper No. 831681, SP-558, October 1983, pp. 37-50.

1.15. Hirschfeld, T. and Coates, J.P., “Computerized Infrared Spectroscopy: FT -IR and Dispersive”, SAVANT IR -104, SAVANT, P.O. Box 3670, Fullerton, CA 92634, USA, 1983 -- audio/visual publication.

1.16. Coates, J.P., Setti, L.C., McCaa, B.B., “The Analytical and Statistical Evaluation of Infrared Spectroscopic Data from Used Diesel Lubricants”, “Heavy Duty Diesel Lubrication”, SAE Paper No. 841373, SP-589, October 1984, pp. 81-98.

1.17. Coates, J.P. and Hannah, R-W., “Computer Based Infrared Search Systems", "Fourier Transform Infrared Spectroscopy”, Ed. T.Theophanides, D.Reidel Publ. Co., Dordrecht, Netherlands, 1984, pp. 167- 185 -- book chapter.

1.18. Coates, J.P. and Setti, L.C., “Oils, Lubricants and Petroleum Products-- Characterization by Infrared Spectra”, Marcel Dekker Inc. New York, 1985 -- book.

1.19. Coates, J.P., “Structural and Chemical Characterization of Neopentyl Polyol Esters by Infrared Spectroscopy”, ASLE Transactions, 29, 2, (1986), pp. 185-195.

1.20. Coates, J.P. and Setti, L.C., “Infrared Spectroscopic Methods for the Study of Lubricant Oxidation Products”, ASLE Transactions, 29, 3, (1986), pp. 394 -401.

1.2 1. Coates J.P. and Setti, L.C., “Infrared Spectroscopy as a Tool for Monitoring Oil Degradation" "Aspects of Lubricant Oxidation”, ASTM STP 916, Ed. W.H.Stadtmiller and A.N.Smith, American Society for Testing and Materials, Philadelphia, 1986, pp. 57-78 -- book chapter.

1.22. Coates, J.P., D'Agostino, J.M. and Friedman, C.R ., “Quality Control Analysis by Infrared Spectroscopy, Part 1: Sampling”, Am. Lab., 18, (11), pp. 82-86, (1986).

1.23. Coates, J.P., D'Agostino, J.M. and Friedman, C.R ., “Quality Control Analysis by Infrared Spectroscopy, Part 2: Practical Applications”, Am. Lab., 18, (12), pp. 40 -46, (1986).

1.24. Refner, J.A., Coates, J.P. and Messerschmidt, R.G., “Chemical Microscopy with FT -IR microspectrometry”, Am. Lab., 19, (4), pp. 86-97, (1987).

1.25. Roush, P.B., Hannah, R.W., Coates, J.P., Dunn, A. and Willis, H-A., “Application of Curve Fit and Deconvolution to Polymer Analysis”, “Fourier Transform Infrared Characterization of Polymers”, Ed. Hatsuo Ishida, Plenum Press, 1987, pp. 261-279 -- book chapter.

1.26. Coates, J.P., “Instrumentation for Infrared Spectroscopy”, “Analytical Instrumentation Handbook”, Ed. Galen W. Ewing, Marcel Dekker Inc., Chapter 7, pp. 233-279, New York, 1990 -- book chapter.

1.27. Coates, J.P., Rein, A. and Morris, K., “FT -IR in the QC Laboratory, Part 1: The requirements of the production and routine analytical laboratory”, Am. Lab., 20, (2), pp. 117-124, (1988).

1.28. Coates, J.P., “A Practical Approach to Quantitative Methods of Spectroscopic Analysis”, “Computer Methods in UV, Visible and IR Spectroscopy”, Ed. William 0. George, Royal Society of Chemistry Publication, Chapter 7, pp. 95-114, Cambridge, UK, 1990 -- book chapter.

1.29. Coates, J.P. “The Industrial Applications of Infrared Internal Reflectance Spectroscopy”, “Internal Reflection Spectroscopy: Theory and Applications”, Ed. Francis M. Mirabella, Marcel Dekker Inc., 1992 -- book chapter.

1.30. Coates, J.P., “New Chemical Analyzers”, Hydrocarbon Technology International Review, Sterling Publications PLC, UK, pp. 207 -211, 1991/1992.

1.31 .Coates, J.P., “The Role of FTIR Instrumentation in the Chemical Process Industry”, PI Quality, Hitchcock Publishing, Illinois, USA. February 1992.

1.32. Coates, J.P. “Spectrometric Instruments demand Superior Components", Technology Guide, Laser Focus World, February 1992.

1.33. Coates, J.P., “Real-time measurement of octane number and other critical refinery process parameters”, Hydrocarbon Technology International Review, Sterling Publications PLC, UK, pp. 167-169, 1992/1993.

1.34. Coates, J., Davidson, T. and McDermott, L., “The design and Application of Spectrometric Analyzers for the Chemical Process Industry”, Spectroscopy, November/December, 7, (9), pp. 40-49, 1992.

1.35. Coates, J. and Reber, S., “On-line Analyzers: Implementation of Instrument Technology”, American Laboratory, December, 1992, pp.

1.36. Coates, J.P., “New analyzer technology to monitor refinery unit production efficiency”, Hydrocarbon Technology International Review, Sterling Publications PLC, UK, pp. 193-197, 1993/1994.

1.37. Workman, J., Jr., and Coates, J.P., “Multivariate Calibration Transfer”, “The Importance of Standardizing Instrumentation”, Spectroscopy, 8, (9), pp. 36-42, 1993.

1.38. Coates, J.P. “Composition analysis of refinery products”, Hydrocarbon Technology International Quarterly, Sterling Publications PLC, UK, Spring 1994.

1.39. Coates, J.P. “Designing the ideal process analyzer - or at least making the attempt” (Part 1), NIR News, 5, (2), pp. 7-9, 1994.

1.40. Workman, J., Jr., and Coates, J.P., “Herschelometry, Or a Look into the Mind of the Modern Inventor”, Spectroscopy, 9, (5), pp. 42-44, 1994.

1.41. Coates, J.P., “Designing the ideal process analyzer - or at least making the attempt” (Part 2), NIR News, 5, (2), pp. 7/8, 1994.

1.42. Coates, J.P., “Development of a Near-Infrared Analyzer for Refinery Analysis”, Spectroscopy, 9, (9), pp.36-40, 1994

1.43. Coates, J.P., “Towards real-time control of refinery production”, Hydrocarbon Technology International Quarterly, Sterling Publications PLC, UK, Spring 1995.

1.44. Coates, J.P., “Spectral Interpretation: resources and References for Spectral Interpretation, Part 1, Infrared and Raman,” Spectroscopy, 10, (7), pp. 14-17, 1995.

1.45. Ganz, A and Coates, J.P., “Optical Fibers for On-line Spectroscopy - Bringing the Instrument to the Sample,” Spectroscopy, 11, (1), pp. 32-38, 1996.

1.46. Coates, J.P., “The Interpretation of Infrared Spectra: Published Reference Sources,” Applied Spectroscopy Reviews, 31, (1/2), pp.179-192, 1996.

1.47. Bourassa, P.N., Coates, J.P., Plashko, B.E. and Lankin, D.C., “Spectral Interpretation: Questions and Answers - I What to do When the Sample Arrives, Part II, II Interpretations of the First Spectral Unknown Challenge,” Spectroscopy, 11, (5), pp. 24-40, 1996

1.48. Coates, J. P., “Once More into the Unknown: An Analysis of the Second and Third Spectral Unknown Challenges,” Spectroscopy, 11, (6), pp.11-23, 1996

1.49. Coates, J.P., “A New Universal Sampling Tool for Infrared Spectroscopy,” Spectroscopy, 12, (3), pp. 16-20, 1997.

1.50. Coates, J.P., “A Diamond-Based Sampling Accessory for Solid and Liquid Sampling in Infrared Spectroscopy,” American Laboratory, April 1997, pp. 22C-22J.

1.51. Coates, J.P., “Vibrational Spectroscopy: Instrumentation for Infrared and Raman Spectroscopy,” in Analytical Instrumentation Handbook, Ed. Galen W. Ewing, Marcel Dekker Inc., 2nd. Edition, pp. 393-555, 1997.

1.52. Coates, J.P., “A Review of Sampling Methods for Infrared Spectroscopy,” in Applied Spectroscopy, A Compact Reference for Practitioners, Ed. Jerry Workman and Art Springsteen, Academic Press, pp. 49-91, 1998.

1.53. Coates, J.P., “Vibrational Spectroscopy: Instrumentation for Infrared and Raman Spectroscopy,” Applied Spectroscopy Reviews, 33, (4), pp.267-425, 1998.

1.54. Coates, J.P. and Reffner, J.A., “Visualization of Micro-ATR Infrared Spectroscopy,” Spectroscopy, 14, (4), pp. 34-45, 1999.

1.55. Coates, J.P., “A Mathematical Method for the Elimination of Broad Background Interferences from Infrared Spectra,” Applied Spectroscopy Reviews, 34, (1&2), pp.121-138, 1999.

1.56. Coates, J.P., “A review of Current and New Technology Used in Instrumentation for Industrial Vibrational Spectroscopy, Spectroscopy, 14, (10), pp. 20-34, 1999.

1.57. Coates, J.P., “A Practical Approach to the Interpretation of Infrared Spectra,” Encyclopedia of Analytical Chemistry, Ed. R.A. Meyers, J. Wiley & Sons, Ltd., Chichester, UK, pp. 10815-10837, 2000.

1.58. Coates, J.P. and Shelley, P. H., “Infrared Spectroscopy in Process Analysis,” Encyclopedia of Analytical Chemistry, Ed. R.A. Meyers. J. Wiley & Sons, Ltd., Chichester, UK, pp. 8217-8240, 2000.

1.59. Coates, J.P and Reffner, J.A., “Have FTIR…Will Travel,” Spectroscopy, 15, (4), pp. 19-29, 2000.

1.60. Coates, J.P. and Sanders, A., “A Universal Sample Handling System for FT-IR Spectroscopy,” Spectroscopy Europe, Wiley-VCH, 12, (5), pp. 12-22, 2000.

1.61. Coates, J.P. “Digital Difficulties,” Today’s Chemist at Work, American Chemical Society, 9, (10), pp. 15-19, 2000.

1.62. Coates, J.P., “New Micro Spectrometers: Building on the Principle that Simple is Beautiful,” Spectroscopy, 15, (12), 2000.

1.63. Coates, J.P., “Classical Methods of Quantitative Analysis,” Handbook of Vibrational Spectroscopy, Volume 3, Ed. P.R.Griffiths and J. Chalmers, J. Wiley & Sons, Ltd., Chichester, UK, pp. 2235-2257, 2002.

1.64. Coates, J.P. and Nisikida, K., “Infrared and Raman Analysis of Polymers,” Handbook of Plastics Analysis, Ed. J. Bonilla and H. Lobo, Marcel Dekker, NY, pp. 201-340, 2003.

1.65. Coates, J.P., “A New Approach to Near- and Mid-Infrared Process Analysis,” Spectroscopy, 20, (1), 2005, pp. 32-42.

1.66. Coates, J.P., “Infrared Spectrometers: High-Efficiency Sources Shed New Light,” The Photonics Handbook, Laurin Publishing, Pittsfield, MA, pp. H-263 – H-266, 2005

1.67. Fredericks, P., Rintoul, L., and Coates, J.P., “Vibrational Spectroscopy; Instrumentation for Infrared and Raman Spectroscopy,” Ewing’s Analytical Instrumentation Handbook, 3rd Edition, Ed. Jack Cazes, Marcel Decker, New York, NY, pp. 163-238, 2005.

1.68. Coates, J.P., “Infrared Spectroscopy for Process Analytical Applications,” Process Analytical Technology: Spectroscopic Tools and Implementation Strategies for the Chemical and Pharmaceutical Industries, Ed. K. A. Bakeev, Blackwell Publishing, Ames, IA, pp. 91-132, 2005.

1.69. Coates, J.P., “New Technologies for Process Analytical and Quality Control Applications: Compact Raman”, Molecular Spectroscopy Workbench, Ed. Emil Ciurczak, Spectroscopy, 21 (2), pp. 68-74, 2006.

1.70. Coates, J.P., “Think Small: Low-Coast Optical Spectral Measurements for Chemical Sensing”, Spectroscopy, 21 (10), pp. 20-25, 2006

1.71. Coates, J.P., “Think Small Revisited: Handheld Spectroscopy”, Spectroscopy, 22 (5), pp. 28-38, 2007

1.72. Coates, J.P., “Pittcon 2007: New Products and Technologies”, Spectroscopy, 22 (2), pp. 28-36, 2007

US Patents

2.1. U.S. Patent No. 4,365,303, December 1982: “A Method and Apparatus for Determining the Nature of an Unknown Substance, Coates, J.P., Hannah, R.W., Savitzky, A., Ford, M.A. and Carter, H.V.

2.2. US Patent No. 6,138,082, October 2000: “Standardizing between Analytical Instruments”, Coates, John; Wang, Yongdong; Ganz, Alan; Tracy, David and Huppler, David.

2.3. US Patent No. 6,452,179, September 2002: “On-site Analyzer”, Coates, John; Rosenbaum, Neil and Abeneaj, Joseph.

2.4. US Patent No. 6,455, 850, September 2002: “On-site Analyzer having Spark Emission Spectrometer with Even-wearing Electrodes”, Coates, John; Rosenbaum, Neil and Bridgman, Stephen.

2.5. US Patent Application, October 2002: Low-Cost On-Line and In-Line Spectral Sensors Based on Solid-State Source and Detector Combinations for Monitoring Lubricants and Functional Fluids, Coates, John; Mateer, Kenneth and Mellick, Ronald.

2.6. US Patent (Issued October 2005): System and Method for Integrated Sensing and Control of Industrial Processes, Coates, John; Rathgeb, Fernando and Stowell, Rand.

Column Editor: Molecular Spectroscopy Workbench, Spectroscopy, 1985 -1989

3.1. Coates, J.P., “Developing Practical Instrumentation”, Spectroscopy, November, (1985), pp .16.

3.2. Coates, J.P., “Tracking Down Bad Data”, Spectroscopy, 1, 1, (1986), pp .14-16.

3.3. Coates, J.P., “The 1986 Pittsburgh Conference and Exposition: New Instruments for Molecular Spectroscopy”, Spectroscopy, 1, 4, (1986), pp .14-17.

3.4. Coates, J.P., “The Return to the Boardwalk: New Products, News, and Trends from the 37th Pittsburgh Conference and Exposition”, Spectroscopy, 1, 5, (1986), pp. 14-19.

3.5. Coates, J.P., “The Loss of a Great Scientist”, Spectroscopy, 1, 7, (1986), pp. 10- 13.

3.6. Coates, J.P., “Computers in Spectroscopy, Part l”, Spectroscopy, 1, 9, (1986), pp. 14-19.

3.7. Coates, J.P., ‘Computers in Spectroscopy, Part 2”, Spectroscopy, 1, 11, (1986), pp. 14-18.

3.8. Coates, J.P., “Instruments '86, Part l”, Spectroscopy, 1, 12, (1986), pp. 14 -20.

3.9. Coates, J.P., Obremski, R.J., Wooton, D.L. and Bourassa, P.N., “Instruments '86, Part 2”, Spectroscopy, 2, 1, (1987), pp. 14-22.

3.10. Coates, J.P., “Computers in Spectroscopy, Part 3”, Spectroscopy, 2, 4, (1987), pp. 14-22.

3.11. Coates, J.P., “Another Year on the Boardwalk: News, New Products, and Trends from the 38th Pittsburgh Conference and Exposition”, Spectroscopy, 2, 5, (1987), pp. 14-27.

3.12. Coates, J.P., “Computers in Spectroscopy, Part 4: A Potpourri of Hardware and Software”, Spectroscopy, 2, 6, (1987), pp. 14-23.

3.13. Coates, J.P., “Computers in Spectroscopy, Part 5: Something Old, Something New, Something Borrowed, Something Blue”, Spectroscopy, 2, 9, (1987), pp. 14-23.

3.14. Coates, J.P., “The End-of-the-Year Wrap-up and What's New in Molecular Spectroscopy Instrumentation”, Spectroscopy, 2, 12, (1987), pp. 10-18.

3.15. Coates, J.P., “Computers in Spectroscopy, Part 6: A Matter of Production and Presentation”, Spectroscopy, 3, 2, (1988), pp. 14 -20.

3.16. Coates, J.P. “Coffee and Beignets for Breakfast - A Brief Return to New Orleans: A Review of the Pittsburgh Conference, Part l”, Spectroscopy, 3, 4, (1988), pp. 14-

3.17. Coates, J.P. “New Orleans Revisited: Pittsburgh Conference Review, Part 2”, Spectroscopy, 3,5, (1988), pp. 14-

3.18. Coates, J.P., “Automated Compound Identification and Material Characterization, Part 1: A Perspective of the Status Quo”, Spectroscopy, 3, 3, (1988), pp. 14- 18.

3.19. Coates, J.P., “Automated Compound Identification and Material Characterization, Part 2: Defining the Problems”, Spectroscopy, 3, 6, (1988), pp. 14-

3.20. Coates, J.P., “Automated Compound Identification and Material Characterization, Part 2: Extracting More from the Spectrum”, Spectroscopy, 3, 1 1, (1988), pp. 18-26.

3.21. Coates, J.P. “Computers in Spectroscopy, Part 7: The World of Standard”, “Things that are Not the Same are Different”, Spectroscopy, 3, 10, (1988), pp. 14-

3.22. Coates, J.P. “Perception is Reality... Or is It?”, Spectroscopy, 4, 1, (1989), pp. 15-17.

Column Editor: The Process Lines, Spectroscopy, 1995 - 1996

4.1. Coates, J.P., “Process Analytical Instrumentation: To Be or Not to Be? Fact or Fantasy?”, Spectroscopy, 10, 2, (1995), pp. 28-31.

4.2. Coates, J.P., “Process Spectroscopy Sounds Good: But is there Motivation for Changing the Status Quo”, Spectroscopy, 10, 5, (1995), pp. 20-23.

4.3. Coates, J.P., “Technology and Techniques: Meeting the Needs of Process Spectroscopy Applications”, Spectroscopy, 10, 6, (1995), pp. 27-30

4.4. Coates, J.P. “Clarifying the Issues: Further Reflections on Filter Analyzers in Process IR Spectroscopy,” Spectroscopy, 10, (1995), pp. 24-26


http://www.coates-consulting.com/publications

CDEX's New Technical Director John P. Coates, PhD has written and published much that is cited in the literature. John P. Coates, PhD (Author)

These represent a few/there are many

http://books.google.com/books?id=Cb5dewIqHzsC&pg=PA53&lpg=PA53&dq=%22John+P.+Coates%22+spectroscopy&source=bl&ots=xsKgiRBslw&sig=5Q-6ue8Ar0-he5EnEzBVscsnacI&hl=en&sa=X&ei=UNcVVIDCBYSyogSt3IH4Bg&ved=0CFcQ6AEwBw#v=twopage&q=%22John%20P.%20Coates%22%20spectroscopy&f=false

Page 52 Chapter 3
The Industrial Applications of Infrared Internal Reflectance Spectroscopy
John P. Coates Perkin-Elmer-Process Analytical Instruments, Pomona, California

Next-generation Spectroscopic Technologies (Proceedings of SPIE)Paperback

by John P. Coates (Author) et al

Oils, Lubricants, and Petroleum Products: Characterization by Infrared Spectra

by John P. Coates (Author), Lynn C. Setti (Compiler)


http://www.amazon.co.uk/Next-generation-Spectroscopic-Technologies-Proceedings-SPIE/dp/0819469254/ref=sr_1_1?s=books&ie=UTF8&qid=1410717573&sr=1-1


http://www.amazon.co.uk/Oils-Lubricants-Petroleum-Products-Characterization/dp/0824774124/ref=sr_1_4?s=books&ie=UTF8&qid=1410717573&sr=1-4

http://link.springer.com/chapter/10.1007/978-94-009-6418-1_12

John Coates = CDEX. He provides significant contributions to vibrational spectroscopy while working in the industry. Worked with Perkin Elmer, Dow Chemical, Nicolet Instruments, & SENSOR DEVELOPMENT. Dr. Coates is one of the three CDEX representatives presenting this week!

http://www.spectroscopyonline.com/spectroscopy/The-Coblentz-Society---Williams-Wright-Award/ArticleStandard/Article/detail/807816

Doctor Coates also working with tunable mid IR laser spectrometry and Raman

1.Shedding New Light on Materials Analysis: Tunable Mid-IR Laser Spectrometry - - Spectroscopy is important for accurate handheld measurements, in which shorter observation times are necessary. John Coates

2.Application of Raman Spectroscopy to Lubricants, Lubricated 46 Surfaces, and Lubrication Phenomena - - Spectroscopy lubricant additives, and solid lubricants; the study of vapor-phase lubrication;

http://www.spectroscopyonline.com/spectroscopy/article/articleDetail.jsp?id=685449

http://www.spectroscopyonline.com/spectroscopy/article/articleDetail.jsp?id=731264